Skip to main content

Implementation of the Independent Medicines and Medical Devices Safety Review recommendations

EDM (Early Day Motion) 78: tabled on 18 May 2022

Tabled in the 2022-23 session.

This motion has been signed by 26 Members. It has not yet had any amendments submitted.

Motion text

That this House notes that sodium valproate can cause serious problems in a developing baby; further notes that 10 percent of babies whose mothers take sodium valproate during pregnancy are at risk of having a birth defect, and up to 40 percent have problems with development and learning as they grow; welcomes the July 2020 Independent Medicines and Medical Devices Safety Review; and calls on the Government to implement its recommendations in full, including paying compensation to people disabled by sodium valproate.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

There are no withdrawn signatures for this motion.